The 'responsive and pragmatic' team at DLA Piper leverages the firm's international network of offices to act for global pharma companies in a range of matters. Marco de Morpurgo divides his time between the Rome and Brussels offices, and is well versed in assisting with market access issues, advertising matters and product classification cases; he co-heads the practice with Joost Haans. Jean-Christophe Top joined the team in January 2024.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘The DLA team is responsive and pragmatic. Because of their global reach, they are able to act as a trusted partner for a wide range of matters in various jurisdictions. ’
‘Kristof De Vulder is very approachable, able to place himself in the client's position and provide valuable and actionable advice.’
Clients clés
- Acadia Pharmaceuticals
- Eqology
- Guerbet
- Intra-Cellular Therapies
- IVC Evidensia
- NeuroTrauma Sciences
- NewLeaf
- Nipro
- Owkin
- Phuse
Points forts
- Assisting Nipro with a broad range of matters, including research, distribution and manufacturing contracts, compliance issues and packaging issues.
- Advising Acadia Pharmaceutical on its entrance into the European market.
Avocats
Responsable de la pratique
Marco de Morpurgo; Joost Haans
Autres avocats clés
Kristof De Vulder; Jean-Christophe Top